Literature DB >> 27408045

Ocular Surface Changes in Primary Open Angle Glaucoma with Long Term Topical Anti Glaucoma Medication.

A P Kamath1, S Satyanarayana2, Fea Rodrigues3.   

Abstract

BACKGROUND: Topical life long anti glaucoma medication forms the mainstay of treatment of primary open angle glaucoma. Their long term usage can cause changes in conjunctival epithelium.
METHODS: Hundred cases of primary open angle glaucoma were divided into four groups of 25 patients each. Each group was put on Timolol, Pilocarpine, Brimonidine and Latanoprost respectively. Ocular surface changes were monitored using Schirmer's test, tear film break up time (BUT) and conjunctival impression cytology. RESULT: Altered Schirmer's test value was seen in 40% of patients and reduced tear film BUT values in 26%, at the end of one year. These changes were more in patients treated with timolol. Changes in conjunctival cytology such as decrease in goblet cell density, squamous metaplasia and presence of inflammatory cells were seen in significant number of patients at the end of one year treatment. There was direct relation of duration of treatment to various ocular surface changes.
CONCLUSION: Ocular surface changes are seen in significant number of patients of primary open angle glaucoma at the end of one year follow up with topical anti glaucoma therapy. Conjunctival impression cytology is a non invasive technique to monitor these changes.

Entities:  

Keywords:  Goblet cell density; Ocular surface changes; Primary open angle glaucoma; Squamous metaplasia

Year:  2011        PMID: 27408045      PMCID: PMC4922031          DOI: 10.1016/S0377-1237(07)80011-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

1.  Adverse effects of topical antiglaucoma drugs on the ocular surface.

Authors:  M K Arici; D S Arici; A Topalkara; C Güler
Journal:  Clin Exp Ophthalmol       Date:  2000-04       Impact factor: 4.207

Review 2.  Side effects of antiglaucomatous drugs on the ocular surface.

Authors:  C Baudouin
Journal:  Curr Opin Ophthalmol       Date:  1996-04       Impact factor: 3.761

3.  Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Authors:  C Baudouin; C de Lunardo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

4.  Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group.

Authors:  L J Katz
Journal:  Am J Ophthalmol       Date:  1999-01       Impact factor: 5.258

5.  Influence of beta-adrenergic antagonists on tear secretion in children.

Authors:  Elzbieta Samochowiec-Donocik; Bronisława Koraszewska-Matuszewska
Journal:  Pol J Pharmacol       Date:  2004 Nov-Dec

6.  Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis.

Authors:  C Costagliola; A D Prete; C Incorvaia; R Fusco; F Parmeggiani; A Di Giovanni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-11       Impact factor: 3.117

7.  Conjunctival impression cytology in contact lens wearers.

Authors:  Priya Simon; Saramma G Jaison; Sudesh K Chopra; Sunitha Jacob
Journal:  Indian J Ophthalmol       Date:  2002-12       Impact factor: 1.848

8.  Ocular surface alteration after long-term treatment with an antiglaucomatous drug.

Authors:  J M Herreras; J C Pastor; M Calonge; V M Asensio
Journal:  Ophthalmology       Date:  1992-07       Impact factor: 12.079

9.  Ocular surface changes induced by topical antiglaucoma monotherapy.

Authors:  Barbara Cvenkel; Alojz Ihan
Journal:  Ophthalmologica       Date:  2002 May-Jun       Impact factor: 3.250

10.  Effect of timolol with and without preservative on the basal tear turnover in glaucoma.

Authors:  E V Kuppens; C A de Jong; T R Stolwijk; R J de Keizer; J A van Best
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

  10 in total
  2 in total

1.  Impact of Ocular Surface Disease Treatment in Patients with Glaucoma.

Authors:  Ana Luiza Mylla Boso; Erica Gasperi; Leticia Fernandes; Vital Paulino Costa; Monica Alves
Journal:  Clin Ophthalmol       Date:  2020-01-14

Review 2.  A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications.

Authors:  Xiaoyu Zhou; Xinyue Zhang; Dengming Zhou; Yang Zhao; Xuanchu Duan
Journal:  Ophthalmol Ther       Date:  2022-08-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.